Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.75p
   
  • Change Today:
    -0.15p
  • 52 Week High: 9.00
  • 52 Week Low: 2.25
  • Currency: UK Pounds
  • Shares Issued: 1,061.80m
  • Volume: 1,686,385
  • Market Cap: £71.67m
  • Beta: 1.05

Regulatory News

Q3 2025 Trading Update 23-Oct-2025 07:00 RNS
Grant of Share Options to Chief Executive Officer 14-Oct-2025 15:01 RNS
Total Voting Rights 01-Oct-2025 08:00 RNS
Positive efficacy and tolerance in pediatric trial 01-Oct-2025 07:02 RNS
£1.5 million placing supporting growth of A... 15-Sep-2025 07:00 RNS
ACCRUFeR® assigned Priority Review in US by... 04-Sep-2025 07:03 RNS
Interim results for the six months ended 30 Jun 25 03-Sep-2025 14:17 RNS
Data published -European Journal of Heart Failure 27-Aug-2025 07:13 RNS
Interim results for the six months ended 30 Jun 25 21-Aug-2025 12:06 RNS
Q2 2025 Trading Update 23-Jul-2025 07:00 RNS
Result of AGM 22-May-2025 17:06 RNS
Audited results for the year ended 31 Dec 2024 24-Apr-2025 07:06 RNS
Licence Agreement in Japan for ACCRUFeR® 22-Apr-2025 07:01 RNS
Q1 2025 Trading Update 17-Apr-2025 11:23 RNS
ACCRUFeR® launched in Canada 11-Mar-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 6.75p
Change Today -0.15p
% Change -2.17 %
52 Week High 9.00
52 Week Low 2.25
Volume 1,686,385
Shares Issued 1,061.80m
Market Cap £71.67m
Beta 1.05

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average
Price Trend
58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average
77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average
Income Not Available
Growth
64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 06-Nov-2025

Time Volume / Share Price
16:20 165,421 @ 6.60p
16:15 68,228 @ 6.74p
16:03 128,750 @ 6.60p
16:03 150,000 @ 6.70p
16:02 29,500 @ 6.70p

STX Key Personnel

CEO Anders Lundstrom

Top of Page